Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests protein intake and exercise for muscle loss in older adults with kidney disease

Compares two protein amounts with home exercise in older adults with early kidney disease.

Plain-language title generated from the registry record
Registry title: The Optimal Protein Intake to Enhance Muscle Mass in Elderly Patients With Pre-dialysis Chronic Kidney Disease

Key facts

Where
Bangkok, ThailandSee the site

Where in Thailand

  • King Chulalongkorn Memorial HospitalBangkok, ThailandNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chulalongkorn University
Trial code
NCT07102667
Record updated
11 August 2025
Original description
The goal of this clinical trial is to determine whether increasing protein intake in elderly adults with pre-dialysis chronic kidney disease, in combination with resistance exercise, improves muscle mass without worsening renal function.The main questions it aims to answer are:Read full original descriptionShow less

The Optimal Protein Intake to Enhance Muscle Mass in Elderly Patients With Pre-dialysis Chronic Kidney Disease: A Randomized Active-Controlled Trial

The goal of this clinical trial is to determine whether increasing protein intake in elderly adults with pre-dialysis chronic kidney disease, in combination with resistance exercise, improves muscle mass without worsening renal function.The main questions it aims to answer are:

* Does a protein intake of 1.2 g/kg BW/day combined with exercise improve muscle mass better than a protein intake of 1.0 g/kg BW/day? * Does a protein intake of 1.2 g/kg BW/day combined with exercise lead to greater improvements in muscle strength and function? * Does a protein intake of 1.2 1.2 g/kg BW/day combined with exercise cause a decline in renal function (eGFR) compared to a protein intake of 1.0 1.2 g/kg BW/day?

Researchers will compare a group assigned to intake 1.2 g/kg BW/day of protein with another group assigned to intake 1.0 g/kg BW/day, to assess whether the higher intake improves muscle mass and physical performance without causing harm.

Participants will

* be assessed for body composition, physical performance and nutritional intake. * be assigned to consume protein at either 1.2 or 1.0 g/kg/day. * perform a home-based resistance exercise program using resistance bands. * provide blood and urine sample to monitor renal function. * visit the clinic at weeks 12 and 24 for repeated measurement.

Inclusion: Thai adults aged ≥ 65 years; Chronic kidney disease with estimated glomerular filtration rate (eGFR) 30-59 ml/min/1.73 m2; Sarcopenia or presarcopenia (diagnosis based on Asian Working Group for Sarcopenia (AWGS) 2019 definition).

Exclusion: Limitations of body measurements and interpretation using Bioelectrical Impedance Analysis (BIA) e.g. presence of pacemaker, surgical metal implants; Active cardiopulmonary disease(s) or uncontrolled hypertension with contraindications to resistance training; Physically or cognitively unable to participate in the resistance exercise program (e.g. dementia), as determined by the attending physician; Meets the definition of AKI or AKD, defined as alterations in kidney function within the past 3 months; Severe vitamin D deficiency (25-OH Vitamin D level < 10 ng/mL); Refuses to give consent to participate in the study.

ClinicalTrials.gov NCT07102667